Bottom-up proteomic analysis of single HCT 116 colon carcinoma multicellular spheroids

Rapid Communications in Mass Spectrometry

Volumn 29, Issue 7, 2015, Pages 654-658

  Feist, Peter E ^a   Sun, Liangliang ^a   Liu, Xin ^a   Dovichi, Norman J ^a   Hummon, Amanda B ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; SEARCH ENGINES;

BIOLOGICAL RESEARCH; BOTTOM UP; COLON CARCINOMA; MODELLING SYSTEMS; MULTICELLULAR SPHEROID; PROTEOMIC ANALYSIS; PROTEOMIC PROFILES; RANDOM VARIATION; SMALL SAMPLE SIZE; THREE DIMENSIONAL CELL CULTURE;

PROTEINS;

PROTEOME;

CHEMISTRY; HCT116 CELL LINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MULTICELLULAR SPHEROID; PROCEDURES; PROTEOMICS; TANDEM MASS SPECTROMETRY; TISSUE CULTURE TECHNIQUE; TUMOR CELL CULTURE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HCT116 CELLS; HUMANS; PROTEOME; PROTEOMICS; SPHEROIDS, CELLULAR; TANDEM MASS SPECTROMETRY; TISSUE CULTURE TECHNIQUES; TUMOR CELLS, CULTURED;

EID: 84937808854     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.7150     Document Type: Article

References (24)

1. D. J. Maltman, S. A. Przyborski,. Developments in three-dimensional cell culture technology aimed at improving the accuracy of in vitro analyses. Biochem. Soc. Trans. 2010, 38, 1072.
2. T. Korff, H. G. Augustin,. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J. Cell. Biol. 1998, 143, 1341.
3. M. A. Faute dit, L. Laurent, D. Ploton, M.-F. Poupon, J.-C. Jardillier, H. Bobichon,. Distinctive alterations of invasiveness, drug resistance and cell-cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant. Clin. Exp. Metastasis 2002, 19, 161.
4. L. Gaedtke, L. Thoenes, C. Culmsee, B. Mayer, E. Wagner,. Proteomic analysis reveals differences in protein expression in spheroid versus monolayer cultures of low-passage colon carcinoma cells. J. Proteome Res. 2007, 6, 4111.
5. H. R. Kumar, X. Zhong, D. J. Hoelz, F. J. Rescorla, R. J. Hickey, L. H. Malkas, J. A. Sandoval,. Three-dimensional neuroblastoma cell culture: proteomic analysis between monolayer and multicellular tumor spheroids. Pediatr. Surg. Int. 2008, 24, 1229.
6. D. Paul, A. Kumar, A. Gajbhiye, M. K. Santra, R. Srikanth,. Mass spectrometry-based proteomics in molecular diagnostics: Discovery of cancer biomarkers using tissue culture. BioMed. Res. Int. 2013, 2013, e783131.
7. K. M. McMahon, M. Volpato, H. Y. Chi, P. Musiwaro, K. Poterlowicz, Y. Peng, A. J. Scally, L. H. Patterson, R. M. Phillips, C. W. Sutton,. Characterization of changes in the proteome in different regions of 3D multicell tumor spheroids. J. Proteome Res. 2012, 11, 2863.
8. E. van Vliet, S. Morath, C. Eskes, J. Linge, J. Rappsilber, P. Honegger, T. Hartung, S. Coecke,. A novel in vitro metabolomics approach for neurotoxicity testing, proof of principle for methyl mercury chloride and caffeine. NeuroToxicol. 2008, 29, 1.
9. X. Liu, E. M. Weaver, A. B. Hummon,. Evaluation of therapeutics in three-dimensional cell culture systems by MALDI imaging mass spectrometry. Anal. Chem. 2013, 85, 6295.
10. N. Takai, Y. Tanaka, H. Saji,. Quantification of small molecule drugs in biological tissue sections by imaging mass spectrometry using surrogate tissue-based calibration standards. Mass. Spectrom. (Tokyo) 2014, 3, A0025.
11. H. Ye, R. Mandal, A. Catherman, P. M. Thomas, N. L. Kelleher, C. Ikonomidou, L. Li,. Top-down proteomics with mass spectrometry imaging: A pilot study towards discovery of biomarkers for neurodevelopmental disorders. PLoS ONE 2014, 9, e92831.
12. H. Li, A. B. Hummon,. Imaging mass spectrometry of three-dimensional cell culture systems. Anal. Chem. 2011, 83, 8794.
13. N. Wang, M. Xu, P. Wang, L. Li,. Development of mass spectrometry-based shotgun method for proteome analysis of 500 to 5000 cancer cells. Anal. Chem. 2010, 82, 2262.
14. P. K. Smith, R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, D. C. Klenk,. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150, 76.
15. Micro BCA Protein Assay Kit. Available: http://www.piercenet.com/product/micro-bca-protein-assay.
16. L. Sun, G. Zhu, N. J. Dovichi,. Comparison of LTQ-Orbitrap Velos and Q-Exactive for proteomic analysis of 1-1000 ng raw 264.7 cell lysate digests. Rapid Commun. Mass Spectrom. 2013, 27, 157.
17. J. Cox, M. Mann,. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 2008, 26, 1367.
18. D. Pruksakorn, K. Lirdprapamongkol, D. Chokchaichamnankit, P. Subhasitanont, K. Chiablaem, J. Svasti, C. Srisomsap,. Metabolic alteration of HepG2 in scaffold-based 3-D culture: proteomic approach. Proteomics 2010, 10, 3896.
19. U. Rajcevic, J. C. Knol, S. Piersma, S. Bougnaud, F. Fack, E. Sundlisaeter, K. Søndenaa, R. Myklebust, T. V. Pham, S. P. Niclou, C. R. Jiménez,. Colorectal cancer derived organotypic spheroids maintain essential tissue characteristics but adapt their metabolism in culture. Proteome Sci. 2014, 12, 39.
20. J. A. Sandoval, D. J. Hoelz, K. E. Turner, F. J. Rescorla, R. J. Hickey, L. H. Malkas,. Neuroblastoma 3D cell culture: Proteomic differences between cancer spheroids and monolayers. AACR Meet. Abstr. 2006, 2006, 1019.
21. H. B. Gutstein, J. S. Morris, S. P. Annangudi, J. V. Sweedler,. Microproteomics: Analysis of protein diversity in small samples. Mass Spectrom. Rev. 2008, 27, 316.
22. A. M. J. Crowell, M. J. Wall, A. A. Doucette,. Maximizing recovery of water-soluble proteins through acetone precipitation. Anal. Chim. Acta 2013, 796, 48.
23. J. Cox, M. Y. Hein, C. A. Luber, I. Paron, N. Nagaraj, M. Mann,. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Proteomics 2014, 13, 2513.
24. J. Cox, M. Mann,. 1D and 2D annotation enrichment: a statistical method integrating quantitative proteomics with complementary high-throughput data. BMC Bioinformatics 2012, 13, S12.